CT MPJE Connecticut MPJE –
Comprehensive Review 2026/2027 Practice
Exam 2026/2027 — Comprehensive
Connecticut Pharmacy Law & Practice |
Exam-Style MCQs with Correct Answers &
Detailed Rationales |
1. A Connecticut pharmacist receives a prescription for a
controlled substance that contains all required elements
except the patient's address. The patient is known to the
pharmacy and the address is already documented in the
pharmacy's records. What is the best course of action?
A. Dispense immediately because the patient's address is
already on file
B. Ask the patient to supply the address and add it to the
prescription before dispensing
C. Have the technician add the address without pharmacist
involvement
D. Dispense only if the prescriber verbally confirms the
address
Answer: B
The pharmacist should ensure that the prescription contains
the information required by law before dispensing. The fact
that the pharmacy already has the patient's address does not
automatically cure an incomplete prescription. A technician
should not independently make a legally significant alteration
,to a prescription, and verbal confirmation from the prescriber
is not necessarily the appropriate mechanism for every
missing element.
─────
2. Which situation most clearly creates a conflict with the
pharmacist's professional duty to protect patient
confidentiality?
A. Discussing a patient's medication history privately with the
patient's prescriber
B. Providing information to another pharmacist involved in
the patient's care
C. Discussing a patient's controlled-substance therapy loudly
where unrelated customers can hear
D. Documenting an intervention in the patient's pharmacy
record
Answer: C
Patient information should be disclosed only when there is an
appropriate professional or legal basis, and reasonable
safeguards should be used to prevent unauthorized disclosure.
Discussing protected information loudly in a public area
creates an avoidable confidentiality risk, whereas
communication with members of the patient's care team and
appropriate documentation can be legitimate uses of patient
information.
─────
, 3. A pharmacist receives an electronic prescription for a
Schedule II controlled substance. The prescription
appears valid, but the pharmacist has a reasonable
concern that the prescriber may not have authorized it.
What is the most appropriate next step?
A. Fill it because electronic prescriptions are presumed valid
B. Contact the prescriber or an appropriate authorized source
to resolve the concern before dispensing
C. Ask the patient to contact the prescriber and then dispense
without further verification
D. Convert it to a paper prescription
Answer: B
Electronic transmission does not eliminate the pharmacist's
corresponding responsibility to determine that a controlled-
substance prescription is legitimate. When a pharmacist has a
reasonable concern about authenticity or authorization, the
concern should be resolved before dispensing. Simply relying
on the electronic format or shifting the responsibility entirely
to the patient does not adequately address the pharmacist's
professional duty.
─────
4. Which statement best describes the pharmacist's
corresponding responsibility when dispensing a
controlled substance?
A. The pharmacist is responsible only for verifying the
prescriber's license
B. The pharmacist shares responsibility for ensuring that the
, prescription is issued for a legitimate medical purpose
C. The pharmacist may dispense any controlled-substance
prescription presented by a licensed practitioner
D. The pharmacist's responsibility ends once the prescription
is entered into the computer system
Answer: B
Controlled-substance dispensing requires professional
judgment regarding legitimacy and lawful purpose, not merely
verification that the prescriber holds a license. A pharmacist
who identifies red flags cannot ignore them simply because
the prescription otherwise appears technically complete. The
tempting alternative that licensing alone is sufficient fails to
account for the pharmacist's corresponding responsibility.
─────
5. A patient presents a prescription for a Schedule II
medication several days after the date written. The
prescription otherwise appears valid. Which principle
should guide the pharmacist's decision?
A. Every Schedule II prescription can be filled at any time
until the patient turns 21
B. Schedule II prescriptions may generally be refilled
repeatedly if the prescriber intended long-term treatment
C. The pharmacist must apply the applicable federal and
Connecticut time-validity and dispensing requirements
D. The pharmacist may dispense it indefinitely because
Schedule II prescriptions never expire
Answer: C
Comprehensive Review 2026/2027 Practice
Exam 2026/2027 — Comprehensive
Connecticut Pharmacy Law & Practice |
Exam-Style MCQs with Correct Answers &
Detailed Rationales |
1. A Connecticut pharmacist receives a prescription for a
controlled substance that contains all required elements
except the patient's address. The patient is known to the
pharmacy and the address is already documented in the
pharmacy's records. What is the best course of action?
A. Dispense immediately because the patient's address is
already on file
B. Ask the patient to supply the address and add it to the
prescription before dispensing
C. Have the technician add the address without pharmacist
involvement
D. Dispense only if the prescriber verbally confirms the
address
Answer: B
The pharmacist should ensure that the prescription contains
the information required by law before dispensing. The fact
that the pharmacy already has the patient's address does not
automatically cure an incomplete prescription. A technician
should not independently make a legally significant alteration
,to a prescription, and verbal confirmation from the prescriber
is not necessarily the appropriate mechanism for every
missing element.
─────
2. Which situation most clearly creates a conflict with the
pharmacist's professional duty to protect patient
confidentiality?
A. Discussing a patient's medication history privately with the
patient's prescriber
B. Providing information to another pharmacist involved in
the patient's care
C. Discussing a patient's controlled-substance therapy loudly
where unrelated customers can hear
D. Documenting an intervention in the patient's pharmacy
record
Answer: C
Patient information should be disclosed only when there is an
appropriate professional or legal basis, and reasonable
safeguards should be used to prevent unauthorized disclosure.
Discussing protected information loudly in a public area
creates an avoidable confidentiality risk, whereas
communication with members of the patient's care team and
appropriate documentation can be legitimate uses of patient
information.
─────
, 3. A pharmacist receives an electronic prescription for a
Schedule II controlled substance. The prescription
appears valid, but the pharmacist has a reasonable
concern that the prescriber may not have authorized it.
What is the most appropriate next step?
A. Fill it because electronic prescriptions are presumed valid
B. Contact the prescriber or an appropriate authorized source
to resolve the concern before dispensing
C. Ask the patient to contact the prescriber and then dispense
without further verification
D. Convert it to a paper prescription
Answer: B
Electronic transmission does not eliminate the pharmacist's
corresponding responsibility to determine that a controlled-
substance prescription is legitimate. When a pharmacist has a
reasonable concern about authenticity or authorization, the
concern should be resolved before dispensing. Simply relying
on the electronic format or shifting the responsibility entirely
to the patient does not adequately address the pharmacist's
professional duty.
─────
4. Which statement best describes the pharmacist's
corresponding responsibility when dispensing a
controlled substance?
A. The pharmacist is responsible only for verifying the
prescriber's license
B. The pharmacist shares responsibility for ensuring that the
, prescription is issued for a legitimate medical purpose
C. The pharmacist may dispense any controlled-substance
prescription presented by a licensed practitioner
D. The pharmacist's responsibility ends once the prescription
is entered into the computer system
Answer: B
Controlled-substance dispensing requires professional
judgment regarding legitimacy and lawful purpose, not merely
verification that the prescriber holds a license. A pharmacist
who identifies red flags cannot ignore them simply because
the prescription otherwise appears technically complete. The
tempting alternative that licensing alone is sufficient fails to
account for the pharmacist's corresponding responsibility.
─────
5. A patient presents a prescription for a Schedule II
medication several days after the date written. The
prescription otherwise appears valid. Which principle
should guide the pharmacist's decision?
A. Every Schedule II prescription can be filled at any time
until the patient turns 21
B. Schedule II prescriptions may generally be refilled
repeatedly if the prescriber intended long-term treatment
C. The pharmacist must apply the applicable federal and
Connecticut time-validity and dispensing requirements
D. The pharmacist may dispense it indefinitely because
Schedule II prescriptions never expire
Answer: C
